Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T cell response

Ramasamy K., Sadler R., Jeans S., Weeden P., Varghese S., Turner A., Larham J., Gray N., Carty O., Barrett J., Bowcock S., Oppermann U., Cook G., Kyriakou C., Drayson M., Basu S., Moore S., McDonald S., Gooding S., Javaid M.

DOI

10.1101/2021.10.21.21265158

Type

Preprint

Publication Date

2021

Permalink Original publication